E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
Immunological abnormalities in patients with chronic fatigue syndrome.
Tirelli, U, Marotta, G, Improta, S et al. · Scandinavian journal of immunology · 1994 · DOI
Quick Summary
Researchers studied 265 ME/CFS patients and found unusual patterns in their immune cells compared to healthy people. They discovered that certain types of white blood cells called natural killer (NK) cells and B cells were abnormally increased, and these cells showed signs of being overly activated. These immune abnormalities appeared consistent with what other researchers had found in different countries.
Why It Matters
This study provides objective immunological evidence that ME/CFS involves dysregulation of multiple immune cell populations, supporting the biological basis of the disease rather than a purely psychological explanation. These findings could help guide future diagnostic tests and suggest potential therapeutic targets aimed at normalizing immune function.
Observed Findings
Reduced CD3-/CD16+ and CD57+/CD56+ natural killer lymphocytes in CFS patients compared to controls
Expansion of CD8+/CD56+ and CD16-/CD56+ NK cell subsets in CFS patients
Increased expression of cell adhesion molecules (CD11b, CD11c, CD54) and activation antigen (CD38) on NK cells from CFS patients
Significantly reduced percentage and absolute numbers of CD4+CD45RA+ T cells in CFS patients
Elevated circulating B lymphocytes (CD19+) in CFS cases, with expansion of CD5+/CD19+ subset in 11/30 patients
Inferred Conclusions
ME/CFS is associated with multiple immunological abnormalities affecting NK cells, T cells, and B cells
The immune abnormalities identified are consistent with findings from ME/CFS cohorts in other countries, suggesting a consistent biological pattern
NK cell subsets in ME/CFS patients display abnormally increased expression of cell adhesion and activation molecules, a finding reported for the first time in this study
Remaining Questions
Do these immunological abnormalities persist over time, and do they correlate with symptom severity or disease duration?
Are the observed immune abnormalities functional consequences of an initial infection, or do they directly contribute to symptom generation?
What This Study Does Not Prove
This study does not establish whether the observed immune abnormalities are a cause of ME/CFS symptoms or a consequence of the illness; causality cannot be determined from cross-sectional case-control data. It also does not prove these immune markers alone can diagnose ME/CFS or predict treatment response. The findings describe association, not mechanism.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.